Topical and intraperitoneal addition of TB4 increased re-epithelialisation by 42% over saline controls at day 4, and by up to 61% at day 7 post-wounding
AOD-9604 Peptide Therapy in San Diego About the Peptide What Is AOD-9604
Also, most of these studies used Nasal administration of BPC-157 or concluded that it would be the best method of application due to its enhanced healing of a broad range of conditions
Rooted in a scientific, evolutionary approach to health and modern pain management, we exclusively utilize state-of-the-art, pharmaceutical-grade products
To boost levels its recommended one per week for four weeks then one a month
This triple mechanism distinguishes it from dual-agonist peptides like tirzepatide (GLP-1/GIP) and single-agonist compounds like semaglutide (GLP-1 only), making it the most broadly acting incretin-class compound currently under clinical investigation